With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Single-cell Profiling of Childhood Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Charles Mullighan, MD, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Tennessee|
|Single Cell RNA Sequencing of Pediatric High-and Low-Grade Gliomas||University of Colorado Denver / Adam Green, MD||Single-cell Pediatric Cancer Atlas Grant||2019||Colorado|
|Single-Cell Profiling of Acute Myeloid Leukemia for High-Resolution Chemo-immunotherapy Target Discovery||Stanford University School of Medicine / Charles Gawad, MD, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||California|
|Profiling the Transcriptional Heterogeneity of Diverse Pediatric Solid Tumors||St. Jude Children's Research Hospital / Michael Dyer, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Tennessee|
|Single Cell Atlas of Pediatric Osteosarcoma||Dana-Farber Cancer Institute / Natalie Collins, MD/PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Massachusetts|
|Single-cell Gene Expression and Cytosine Modification Profiling in Pediatric Central Nervous System Tumors||Dartmouth College / Brock Christensen, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||New Hampshire|
|The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade||University of Florida / Catherine Flores, PhD||Innovation Grants||2019||Florida|
|Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD & Junwei Shi, PhD||Innovation Grants||2019||Pennsylvania|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|
|Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies||Emory University / Christopher Porter, MD, Curtis Henry, MD & Christopher Flowers, MD||Innovation Grants||2019||Georgia|